about
Systematic review and meta-analysis of opioid antagonists for smoking cessationSpontaneous reductions in smoking during double-blind buprenorphine detoxification.Acute effects of low and high dose alcohol on smoking lapse behavior in a laboratory analogue taskPsychosocial interventions for supporting women to stop smoking in pregnancy.The opioid receptors as targets for drug abuse medicationNaltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersCritical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersEffects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialAn assessment of factors associated with quality of randomized controlled trials for smoking cessation.Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.Endogenous opioid system: a promising target for future smoking cessation medications.Indications for Opioid Antagonists.A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology.Clinical Laboratory Evaluation of Electronic Cigarettes/Electronic Nicotine Delivery Systems: Methodological Challenges.Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
P2860
Q26853570-AC6F7DA8-FE17-445C-8120-605E833DDE93Q33853121-9DA1E325-7A60-42D1-9E1C-56AB1A612692Q34516895-3AA552EB-6E74-4BDF-A239-43A43F515BD2Q34551210-43A4BD3A-1131-48E3-9541-D5F0B32C3001Q35978068-EEC0C675-4509-492B-9F29-3EEA8F25565FQ36263819-2CDCB742-5E15-4469-87AA-9AD7097B8AB5Q36294656-492DB870-3B3E-41BA-BF1B-D9EB4F7B88F6Q36372867-DFBDC971-7682-4D40-AF44-438D543D2912Q36877440-DFEAB005-8391-4AC3-9B2F-2214DD5D9A2CQ37179217-6DBAA9A9-C027-4891-AC44-7DA910B2203EQ37619820-132F3F20-FEB3-4686-BAA4-B16974AEBA63Q38226353-71AAEF83-E4EB-41D0-B1E9-500405AEB3A3Q38747115-4DDBEF70-926D-485C-B0BB-039EE0B8EA59Q38762441-BB834506-C8E8-46BB-8D55-E23D7D11BD8CQ41271163-110B2CC8-4F65-4C72-8AC9-33B53BA017BEQ41657998-BBEF0424-A1E3-4198-8F9C-8B76AA4D165DQ50042559-FD71D732-1509-428D-8919-73DBB3A0E317
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Opioid antagonists for smoking cessation
@ast
Opioid antagonists for smoking cessation
@en
Opioid antagonists for smoking cessation
@en-gb
Opioid antagonists for smoking cessation
@nl
type
label
Opioid antagonists for smoking cessation
@ast
Opioid antagonists for smoking cessation
@en
Opioid antagonists for smoking cessation
@en-gb
Opioid antagonists for smoking cessation
@nl
prefLabel
Opioid antagonists for smoking cessation
@ast
Opioid antagonists for smoking cessation
@en
Opioid antagonists for smoking cessation
@en-gb
Opioid antagonists for smoking cessation
@nl
P2093
P2860
P3181
P1476
Opioid antagonists for smoking cessation
@en
P2093
A Eden Evins
Lindsay F Stead
Tim Lancaster
P2860
P304
P3181
P356
10.1002/14651858.CD003086.PUB3
P407
P577
2013-01-01T00:00:00Z